West Pharmaceutical Services Inc
WST· NYSE
WSTWest Pharmaceutical Services Inc
Source filing unavailable
| Metric | Q2 2010 | Q2 2009 |
|---|---|---|
| Revenue | $281.80M | $261.00M |
| Net Income | $21.70M | $19.70M |
| EPS Diluted | $0.62 | $0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
